Ensuring Community Access to Pharmacist Services Act
Summary
HR3164 expands Medicare Part B to cover pharmacist services but has no funding mechanism and remains in early legislative stage. CVS's recent 5.85% 7-day gain is driven by broader healthcare sector momentum, not this bill.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR3164 is in early legislative stage with no funding mechanism; near-term revenue impact is zero.
- 2.CVS and WBA could be long-term beneficiaries if the bill passes with funding, but no immediate catalyst.
- 3.CVS's recent price strength (+5.85% 7-day) is due to sector momentum, not this bill.
Market Implications
The healthcare sector has seen broad gains recently, with CVS up 5.85% in 7 days and 10.43% in 30 days. However, this movement is disconnected from HR3164's legislative progress. The bill's 117 cosponsors indicate bipartisan support, but without a funding mechanism, the market impact remains speculative. Investors should watch for floor action and potential amendments that include appropriations before adjusting positions in CVS or WBA.
Full Analysis
HR3164 (Ensuring Community Access to Pharmacist Services Act) was introduced on May 1, 2025, and reported out of the House Energy and Commerce and Ways and Means committees via voice vote on May 21, 2026. It now awaits floor action. The bill would amend the Social Security Act to cover pharmacist services under Medicare Part B for evaluation/management visits and testing/treatment of COVID-19, influenza, RSV, and streptococcal pharyngitis, as well as services during declared public health emergencies. However, the bill does not include any funding mechanism or appropriation—it merely authorizes coverage, meaning any actual spending would require separate appropriations. With 117 cosponsors and bipartisan support, the bill has momentum, but its early stage and lack of direct funding limit near-term revenue impact. The most direct beneficiaries are retail pharmacy chains with large clinic networks, such as CVS (operator of MinuteClinic) and Walgreens Boots Alliance (WBA). For CVS, the company's FY2025 revenue of $372.6B (based on SEC filings) dwarfs any potential new service revenue, making the impact immaterial. Current market data shows CVS at $95.92, up 5.85% over 7 days and 10.43% over 30 days, but these moves align with sector-wide advances in healthcare (e.g., UNH, JNJ) rather than specific bill progress. The next legislative step is a House floor vote, followed by Senate consideration (with companion bill S2426). Given the procedural status, no material market impact is expected until funding is attached.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Some confirming evidence found across public data sources
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Protecting Health Care and Lowering Costs Act of 2025
Consolidated Appropriations Act, 2026
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
TRIWEST HEALTHCARE ALLIANCE CORP: $820M Department of Veterans Affairs Contract
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
Association Health Plans Act
Living Donor Protection Act of 2025
I CAN Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →